abstract |
The present description generally refers to nanoparticles having from about 0.2 to about 35 percent by weight of a therapeutic agent; and from about 10 to about 99 percent by weight of a biocompatible polymer as a double block of polylactic acid-polyethylene glycol; Other aspects of the invention include methods for making said nanoparticles. |